David W. Chang - Sir Peter MacCallum Department of Oncology, The University of Melbourne

基本信息

Career Trajectory

Bio

No content for now

Research Interests

Papers共 676 篇Author StatisticsCo-AuthorSimilar Experts

By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选

Figure 4 from KRAS Loss of Heterozygosity Promotes MAPK-Dependent Pancreatic Ductal Adenocarcinoma Initiation and Induces Therapeutic Sensitivity to MEK Inhibition

Sigrid K. Fey,Arafath K. Najumudeen, Dale M. Watt,Laura M. Millett,Catriona A. Ford,Kathryn Gilroy, Rosalin J. Simpson,Kathy McLay,Rosanna Upstill-Goddard,David Chang,William Clark,Colin Nixon,Joanna L. Birch,Simon T. Barry,Jennifer P. Morton,Andrew D. Campbell,Owen J. Sansom

crossref（2025）

Cited0Views0Bibtex

A Novel DNA Repair Protein, N-Myc Downstream Regulated Gene 1 (NDRG1), Links Stromal Tumour Microenvironment to Chemoresistance

Nina Kozlova,Kayla A Cruz,Hanna M Doh, Antoine A Ruzette,Nicholas A Willis, Su Min Hong,Raul S Gonzalez,Monika Vyas,Laura M Selfors,Stephan Dreyer,Rosie Upstill-Goddard, Kerrie L Faia, Steve Wenglowsky, Josh Close,Alica K Beutel, Zeljka Jutric,Michael U J Oliphant, Byanjana Thapa,Martin S Taylor,Venla Mustonen, Pradeep Mangalath,Christopher J Halbrook,Joseph E Grossman,Rosa F Hwang,John G Clohessy,Salla Ruskamo,Petri Kursula,Boryana Petrova,Naama Kanarek, Philip A Cole,David K Chang, Simon F Nørrelykke,Ralph Scully,Taru Muranen

bioRxiv the preprint server for biology (2025)

Cited0Views0WOSBibtex

Supplementary Figure 6 from KRAS Loss of Heterozygosity Promotes MAPK-Dependent Pancreatic Ductal Adenocarcinoma Initiation and Induces Therapeutic Sensitivity to MEK Inhibition

crossref（2025）

Cited0Views0Bibtex

Figure 1 from KRAS Loss of Heterozygosity Promotes MAPK-Dependent Pancreatic Ductal Adenocarcinoma Initiation and Induces Therapeutic Sensitivity to MEK Inhibition

crossref（2025）

Cited0Views0Bibtex

Supplementary Figure 2 from KRAS Loss of Heterozygosity Promotes MAPK-Dependent Pancreatic Ductal Adenocarcinoma Initiation and Induces Therapeutic Sensitivity to MEK Inhibition

crossref（2025）

Cited0Views0Bibtex

Supplementary Figure 3 from KRAS Loss of Heterozygosity Promotes MAPK-Dependent Pancreatic Ductal Adenocarcinoma Initiation and Induces Therapeutic Sensitivity to MEK Inhibition

crossref（2025）

Cited0Views0Bibtex

Prognosis of Restrictive Cardiac Allograft Physiology Following Heart Transplantation

Masaki Tsuji,Jignesh Patel, Michelle Kittleson,David Chang,Evan Kransdorf,Andriana Nikolova,Lily Stern, Nayana Bhatnagar, Jon Kobashigawa

Journal of Cardiac Failureno. 1 (2025): 332

Cited0Views0Bibtex

Figure 3 from KRAS Loss of Heterozygosity Promotes MAPK-Dependent Pancreatic Ductal Adenocarcinoma Initiation and Induces Therapeutic Sensitivity to MEK Inhibition

crossref（2025）

Cited0Views0Bibtex

Figure 2 from KRAS Loss of Heterozygosity Promotes MAPK-Dependent Pancreatic Ductal Adenocarcinoma Initiation and Induces Therapeutic Sensitivity to MEK Inhibition

crossref（2025）

Cited0Views0Bibtex

Supplementary Figure 4 from KRAS Loss of Heterozygosity Promotes MAPK-Dependent Pancreatic Ductal Adenocarcinoma Initiation and Induces Therapeutic Sensitivity to MEK Inhibition

crossref（2025）

Cited0Views0Bibtex

Author Statistics

Co-Author

Co-Institution

D-Core

合作者
学生
导师

No result temporarily, you can search similar Scholar with the same research interest

Data Disclaimer

The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn